No Cover Image

Journal article 464 views 99 downloads

Effects of semaglutide on risk of cardiovascular events across a continuum of cardiovascular risk: combined post hoc analysis of the SUSTAIN and PIONEER trials

Mansoor Husain, Steve Bain Orcid Logo, Anders Gaarsdal Holst, Thomas Mark, Søren Rasmussen, Ildiko Lingvay

Cardiovascular Diabetology, Volume: 19, Issue: 1

Swansea University Author: Steve Bain Orcid Logo

  • 54830.pdf

    PDF | Version of Record

    This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.

    Download (1.21MB)

Check full text

DOI (Published version): 10.1186/s12933-020-01106-4

Published in: Cardiovascular Diabetology
ISSN: 1475-2840
Published: Springer Science and Business Media LLC 2020
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa54830
Tags: Add Tag
No Tags, Be the first to tag this record!
first_indexed 2020-07-30T07:57:18Z
last_indexed 2023-01-11T14:33:04Z
id cronfa54830
recordtype SURis
fullrecord <?xml version="1.0"?><rfc1807><datestamp>2022-12-02T18:45:29.8390829</datestamp><bib-version>v2</bib-version><id>54830</id><entry>2020-07-30</entry><title>Effects of semaglutide on risk of cardiovascular events across a continuum of cardiovascular risk: combined post hoc analysis of the SUSTAIN and PIONEER trials</title><swanseaauthors><author><sid>5399f4c6e6a70f3608a084ddb938511a</sid><ORCID>0000-0001-8519-4964</ORCID><firstname>Steve</firstname><surname>Bain</surname><name>Steve Bain</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2020-07-30</date><deptcode>BMS</deptcode><abstract/><type>Journal Article</type><journal>Cardiovascular Diabetology</journal><volume>19</volume><journalNumber>1</journalNumber><paginationStart/><paginationEnd/><publisher>Springer Science and Business Media LLC</publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint/><issnElectronic>1475-2840</issnElectronic><keywords/><publishedDay>1</publishedDay><publishedMonth>12</publishedMonth><publishedYear>2020</publishedYear><publishedDate>2020-12-01</publishedDate><doi>10.1186/s12933-020-01106-4</doi><url/><notes/><college>COLLEGE NANME</college><department>Biomedical Sciences</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>BMS</DepartmentCode><institution>Swansea University</institution><apcterm/><funders/><projectreference/><lastEdited>2022-12-02T18:45:29.8390829</lastEdited><Created>2020-07-30T08:52:59.9221634</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>Mansoor</firstname><surname>Husain</surname><order>1</order></author><author><firstname>Steve</firstname><surname>Bain</surname><orcid>0000-0001-8519-4964</orcid><order>2</order></author><author><firstname>Anders Gaarsdal</firstname><surname>Holst</surname><order>3</order></author><author><firstname>Thomas</firstname><surname>Mark</surname><order>4</order></author><author><firstname>S&#xF8;ren</firstname><surname>Rasmussen</surname><order>5</order></author><author><firstname>Ildiko</firstname><surname>Lingvay</surname><order>6</order></author></authors><documents><document><filename>54830__18513__18984f7d38774470998da1062db87b00.pdf</filename><originalFilename>54830.pdf</originalFilename><uploaded>2020-10-27T16:15:53.3491819</uploaded><type>Output</type><contentLength>1264965</contentLength><contentType>application/pdf</contentType><version>Version of Record</version><cronfaStatus>true</cronfaStatus><documentNotes>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.</documentNotes><copyrightCorrect>true</copyrightCorrect><language>eng</language><licence>http://creativecommons.org/licenses/by/4.0/</licence></document></documents><OutputDurs/></rfc1807>
spelling 2022-12-02T18:45:29.8390829 v2 54830 2020-07-30 Effects of semaglutide on risk of cardiovascular events across a continuum of cardiovascular risk: combined post hoc analysis of the SUSTAIN and PIONEER trials 5399f4c6e6a70f3608a084ddb938511a 0000-0001-8519-4964 Steve Bain Steve Bain true false 2020-07-30 BMS Journal Article Cardiovascular Diabetology 19 1 Springer Science and Business Media LLC 1475-2840 1 12 2020 2020-12-01 10.1186/s12933-020-01106-4 COLLEGE NANME Biomedical Sciences COLLEGE CODE BMS Swansea University 2022-12-02T18:45:29.8390829 2020-07-30T08:52:59.9221634 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine Mansoor Husain 1 Steve Bain 0000-0001-8519-4964 2 Anders Gaarsdal Holst 3 Thomas Mark 4 Søren Rasmussen 5 Ildiko Lingvay 6 54830__18513__18984f7d38774470998da1062db87b00.pdf 54830.pdf 2020-10-27T16:15:53.3491819 Output 1264965 application/pdf Version of Record true This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. true eng http://creativecommons.org/licenses/by/4.0/
title Effects of semaglutide on risk of cardiovascular events across a continuum of cardiovascular risk: combined post hoc analysis of the SUSTAIN and PIONEER trials
spellingShingle Effects of semaglutide on risk of cardiovascular events across a continuum of cardiovascular risk: combined post hoc analysis of the SUSTAIN and PIONEER trials
Steve Bain
title_short Effects of semaglutide on risk of cardiovascular events across a continuum of cardiovascular risk: combined post hoc analysis of the SUSTAIN and PIONEER trials
title_full Effects of semaglutide on risk of cardiovascular events across a continuum of cardiovascular risk: combined post hoc analysis of the SUSTAIN and PIONEER trials
title_fullStr Effects of semaglutide on risk of cardiovascular events across a continuum of cardiovascular risk: combined post hoc analysis of the SUSTAIN and PIONEER trials
title_full_unstemmed Effects of semaglutide on risk of cardiovascular events across a continuum of cardiovascular risk: combined post hoc analysis of the SUSTAIN and PIONEER trials
title_sort Effects of semaglutide on risk of cardiovascular events across a continuum of cardiovascular risk: combined post hoc analysis of the SUSTAIN and PIONEER trials
author_id_str_mv 5399f4c6e6a70f3608a084ddb938511a
author_id_fullname_str_mv 5399f4c6e6a70f3608a084ddb938511a_***_Steve Bain
author Steve Bain
author2 Mansoor Husain
Steve Bain
Anders Gaarsdal Holst
Thomas Mark
Søren Rasmussen
Ildiko Lingvay
format Journal article
container_title Cardiovascular Diabetology
container_volume 19
container_issue 1
publishDate 2020
institution Swansea University
issn 1475-2840
doi_str_mv 10.1186/s12933-020-01106-4
publisher Springer Science and Business Media LLC
college_str Faculty of Medicine, Health and Life Sciences
hierarchytype
hierarchy_top_id facultyofmedicinehealthandlifesciences
hierarchy_top_title Faculty of Medicine, Health and Life Sciences
hierarchy_parent_id facultyofmedicinehealthandlifesciences
hierarchy_parent_title Faculty of Medicine, Health and Life Sciences
department_str Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine
document_store_str 1
active_str 0
published_date 2020-12-01T04:08:36Z
_version_ 1763753608615034880
score 11.012678

Similar Items